mrd to assess response and inform transplant decision in a relapsed all patient
Published 3 years ago • 109 plays • Length 4:19Download video MP4
Download video MP3
Similar videos
-
6:32
mrd helps predict outcomes and informs transplant decision for an all patient
-
7:24
mrd helps predict outcomes and informs transplant decision for an all patient
-
5:33
mrd-informed treatment decisions in a patient with relapsed myeloma
-
5:42
initiating consolidation prior to transplant based on mrd positivity in acute lymphoblastic leukemia
-
9:20
mrd to support treatment planning in a young, high-risk all patient
-
5:17
approaches to and the use of mrd in all
-
1:39
using mrd to inform allocation of stem cell transplants in all and aml
-
2:41
assessing the prognostic value of ngs-based mrd in adults with all undergoing sct
-
3:35
the role of mrd in all: what defines a complete response?
-
5:40
sensitivity of mrd testing and impact on decisionmaking in all
-
4:26
mrd assessment for surveillance post-treatment in dlbcl
-
1:33:39
the relevance of mrd assessment in the clinical management of multiple myeloma (mm) patients
-
9:35
mrd helps predict outcomes and informs maintenance treatment for a myeloma patient
-
1:37
the importance of mrd assessment before allosct in all
-
56:04
minimal residual disease (mrd) overview | lrf ed forum series
-
3:27
transplant in all after car t-cells & the role of mrd
-
2:18
the utility of measurable residual disease (mrd) assessment in acute myeloid leukemia (aml)
-
2:25
mrd to determine risk of relapse after induction in aml
-
7:24
a conversation on mrd in all